-
Large B cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
Study
EGAS50000000564
-
Chromatin immunoprecipitation linked to next-generation whole genome sequencing (ChIP-Seq) for H3K36me3 in paediatric high grade glioma cell lines KKNS4 and SF188 with and without a G34V mutation in H3F3A
Study
EGAS00001001437
-
Targeted_sequencing_of_genes_recurrently_mutated_in_AML___part2
Study
EGAS00001000570
-
Synergy study: "Tissue resident CD8+ T cell clonal expansion in advanced triple negative breast cancer is associated with response to chemoimmunotherapy"
Study
EGAS50000000527
-
Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial
Study
EGAS50000000470
-
Ballett
Study
EGAS50000000478
-
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer
Study
EGAS50000000483
-
Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers
Study
EGAS50000000484
-
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes
Study
EGAS50000000536
-
Duplex sequencing of selected breast cancer patients
Study
EGAS50000000538
-
WES of breast cancer patients and controls
Study
EGAS50000000539
-
Pipeline Olympics: Continuous benchmarking of computational workflows for DNA methylation sequencing data
Study
EGAS50000000541
-
Single cell RNA and ATAC sequencing data from GBM patients
Study
EGAS50000000547
-
Divergent WNT Signaling and Drug Sensitivity Profiles within Hepatoblastoma Tumors and Organoids
Study
EGAS50000000561
-
Rapid brain tumor classification from sparse epigenomic data
Study
EGAS50000000559
-
Identification and characterization of tertiary lymphoid structures in brain metastases
Study
EGAS50000000563
-
PLCRC_study
Study
EGAS00001000612
-
MutWP5__CRUK_Mutographs_of_Cancer__Lung__PD37920__WG_
Study
EGAS00001003320
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
Whole-genome sequencing of BRCA-mutant breast cancer patient samples from tumour, germline tissue and plasma
Study
EGAS50000000569
-
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
Study
EGAS50000000525
-
Mutational context and diverse clonal development in early and late bladder cancer
Study
EGAS00001000641
-
Sensitive urothelial cancer detection via high volume urine DNA analysis
Study
EGAS50000000630
-
Exploiting evolutionary steering in cancer therapy
Study
EGAS00001003200
-
Tumor Profiler AML Study
Study
EGAS50000000577